Institutional flow

Institutional Flow — Scan of Jul 4, 2026

Stocks that tracked hedge funds and asset managers added to or newly bought in their latest 13F filings, while retail attention is still low — with the fund-by-fund share changes, estimated entry prices and an AI read on why they may be buying.

Next scan: tomorrow by 9:00 AM ET. A new scan is posted every Saturday by 9:00 AM ET.
5stocks qualified
5funds adding
0new positions
$4.33Bheld by those funds

AIThis scan

Compared the two most recent 13F windows across the five configured managers — reportDate 2025-12-31 vs 2026-03-31 (filed Feb 17 and May 15 respectively). 882 CUSIPs passed the raw acceleration filter; after the mega-cap, $1B market-cap, $10M ADV, seven-trading-day earnings, and retail-attention rails, five names survive as candidates where slower-moving capital is genuinely accumulating and the tape has not caught up. The most surprising finding: Berkshire tripled its New York Times Class A position (5.07M → 15.15M shares, +199%) — the largest Berkshire percentage add of the quarter aside from a first-time Delta Air Lines stake — and did it while broadly de-risking (nine full exits including Charter, DoorDash, T-Mobile-adjacent Amazon and UnitedHealth). RenTech and Two Sigma leaned in on the same name incrementally, both above +19%.

How this scan was run

For each of the five configured funds we pulled the last two 13F-HR filings via SEC EDGAR (fetch_13f_holdings) and aggregated share counts by CUSIP across every subsidiary filer — Berkshire in particular files as ~10 insurance-subsidiary managers, and the totals here are the roll-up. A CUSIP qualified when net-adders exceeded net-trimmers across the five funds, aggregate share count grew ≥25% Q/Q OR at least two funds newly opened, no single non-Berkshire fund contributed more than 80% of the aggregate share increase, and there were no put-option positions. Berkshire and Bridgewater were weighted higher for thesis writing because their books turn slowly and the 13F represents most of the signal; RenTech, Citadel and Two Sigma turn intra-quarter, so their acceleration matters only as corroboration. CUSIP-to-ticker was resolved via SEC company_tickers.json with no ambiguities among the final five. Retail-attention scores (Google Trends, mainstream news count, options C/P OI) are approximations from public feeds and Tradier option chains rather than exact metrics. All five funds returned holdings for both windows — no failed-to-return cases.

#1

NYT

The New York Times Company
Communication ServicesMkt cap $12.1BNext earnings Aug 6, 2026
Price
$73.85
Est. fund entry
$83.72-11.8%
Shares held
20.5M
Position value
$1.71B
Funds that added
FundPrior sharesShares nowChange
Berkshire Hathaway5.07M15.1M+199.0%
Renaissance Technologies2.29M2.76M+20.3%
Two Sigma Investments1.94M2.31M+19.1%
Retail attention 4 of 4 signals quiet
Google Trends22/100quiet
News, 30 days14 articlesquiet
Call/put OI1.30quiet
Retail hotlistsNot listedquiet

AIWhy these funds may be buying

Berkshire's Class A stake essentially tripled (5.07M → 15.15M shares), the largest percentage add in the entire Berkshire book this quarter aside from a fresh Delta Air Lines position. The sizing (~$1.1B) fits a Weschler/Combs lieutenant decision rather than Buffett himself, and it comes with RenTech and Two Sigma incrementally leaning in on the same tape. The setup is straightforward: NYT crossed 12M digital subscribers in Q1, ARPU is compounding as bundle attach hits The Athletic and Cooking, and generative-AI content-licensing revenue begins to layer in during H2 pending the OpenAI settlement. Stock has drifted ~12% below the estimated quarter-end aggregate entry, so a patient allocator enters at a discount to where Berkshire built the position.

What would prove it wrong

The float is small enough that a Berkshire trim (or a leaked LP letter) would move it hard. A softer Q3 ad market would dent the print-legacy line, and an adverse ruling in the OpenAI copyright suit compresses the AI-licensing optionality that partially underwrites the thesis.

#2

LEN

Lennar Corporation
Consumer DiscretionaryMkt cap $21.4BNext earnings Sep 17, 2026
Price
$88.21
Est. fund entry
$86.85+1.6%
Shares held
14.3M
Position value
$1.25B
Funds that added
FundPrior sharesShares nowChange
Berkshire Hathaway7.05M10.1M+43.2%
Two Sigma Investments1.54M2.60M+69.5%
Citadel Advisors1.23M1.25M+1.9%
Retail attention 4 of 4 signals quiet
Google Trends18/100quiet
News, 30 days11 articlesquiet
Call/put OI1.40quiet
Retail hotlistsNot listedquiet

AIWhy these funds may be buying

Berkshire already owns NVR, so Lennar is a deliberate doubling-down on the low-cost, land-light operator during the worst homebuilder tape since 2022 — not a diversified sector bet. Lennar bought back its own stock through Q1 while Berkshire added 43%, and management has front-loaded incentives to move inventory before the next rate leg. Two Sigma piling on +69% is the quant confirmation on the same setup. Retail is fixated on rate-cut arithmetic and missing the structural point: last year's spinoff of the Millrose land-holding sub leaves Lennar with a cleaner asset-light story that historically re-rates from ~1.1x book toward the 1.4-1.5x range in a stabilizing housing regime.

What would prove it wrong

A stalled rate-cut path or a further step-down in existing-home turnover would extend the pain into fiscal 2027. Homebuilder margins are sensitive to lumber and incentive intensity — a bad September print could break the technical setup before the thesis has time to compound.

#3

EHC

Encompass Health Corporation
Health CareMkt cap $10.7BNext earnings Aug 1, 2026
Price
$106.46
Est. fund entry
$96.72+10.1%
Shares held
3.05M
Position value
$295.0M
Funds that added
FundPrior sharesShares nowChange
Two Sigma Investments804.9K2.22M+176.1%
Citadel Advisors125.1K515.1K+311.8%
Renaissance Technologies68.2K265.0K+288.6%
Bridgewater Associates35.4K46.4K+31.1%
Retail attention 4 of 4 signals quiet
Google Trends9/100quiet
News, 30 days5 articlesquiet
Call/put OI1.20quiet
Retail hotlistsNot listedquiet

AIWhy these funds may be buying

All four non-Berkshire funds added, and Bridgewater's incremental buy is the tell — Dalio's book usually surfaces demographic-tailwind stories months before the sell side writes the note. Encompass runs the largest inpatient rehab hospital chain in the US and each new IRF opening layers roughly $25M of steady-state revenue at 25%+ EBITDA margins; the 2026 pipeline is 15 hospitals versus 10 last year. Meanwhile CMS is still finalizing the FY2027 IRF rate rule which has netted a 3-4% payment update in each of the past three years. It's a boring compounder that never enters retail conversation, and that quiet is the setup.

What would prove it wrong

A tighter-than-expected CMS rate rule or renewed site-neutral payment debate would compress the entire IRF sector regardless of Encompass's execution. Clinical labor cost re-acceleration is the other perennial risk in this space; management has flagged wage inflation as still above pre-pandemic norms.

#4

AWI

Armstrong World Industries, Inc.
IndustrialsMkt cap $6.8BNext earnings Jul 28, 2026
Price
$158.56
Est. fund entry
$165.42-4.1%
Shares held
1.73M
Position value
$286.0M
Funds that added
FundPrior sharesShares nowChange
Citadel Advisors548.8K800.0K+45.8%
Two Sigma Investments237.9K783.8K+229.4%
Bridgewater Associates17.6K30.8K+74.3%
Renaissance Technologies117.3K118.7K+1.2%
Retail attention 4 of 4 signals quiet
Google Trends5/100quiet
News, 30 days3 articlesquiet
Call/put OI1.40quiet
Retail hotlistsNot listedquiet

AIWhy these funds may be buying

AWI dominates North American commercial-building mineral fiber ceilings — 60%+ share, effectively a duopoly with USG — and is benefiting from two tailwinds the Street underweights: office-to-multifamily conversions (which require new ceilings on every renovated floor) and re-shoring-driven light-industrial construction. Four funds added simultaneously, three of them >45%, on a name with almost no retail coverage. Q1 revenue +15% YoY at ~40% gross margin says pricing has stuck through the raw-material swing. The stock trades ~4% below where these funds accumulated at quarter end.

What would prove it wrong

AWI is small enough that a single quant unwind could move the tape 8-10% in a session. Non-residential construction starts have softened for two consecutive quarters; a full commercial-real-estate air pocket would pause the volume story regardless of pricing discipline.

#5

LNG

Cheniere Energy, Inc.
EnergyMkt cap $51.8BNext earnings Aug 6, 2026
Price
$245.97
Est. fund entry
$283.44-13.2%
Shares held
2.81M
Position value
$796.0M
Funds that added
FundPrior sharesShares nowChange
Two Sigma Investments604.8K1.39M+129.5%
Citadel Advisors492.9K917.9K+86.2%
Bridgewater Associates71.8K186.4K+159.6%
Renaissance Technologies304.1K314.2K+3.3%
Retail attention 3 of 4 signals quiet
Google Trends16/100quiet
News, 30 days18 articlesbusy
Call/put OI1.50quiet
Retail hotlistsNot listedquiet

AIWhy these funds may be buying

Bridgewater more-than-doubling Cheniere is the standout signal — Dalio's book is macro and the LNG-export + European-gas-price setup is exactly the shape it usually takes. Corpus Christi Stage 3 hit fifth-train commissioning this quarter and Sabine Pass expansion is on the FID clock; both add incremental fixed-fee take-or-pay contracts through 2028. Stock has drifted ~13% below the aggregated quarter-end entry price, so a patient allocator is now buying below where Bridgewater and Citadel accumulated. Distributable cash flow trajectory covers the expanded buyback authorization at current strip.

What would prove it wrong

A collapse in European TTF prices would compress the merchant tail even though the base contracts are fixed-fee. A permitting reversal at DOE — or a decision to slow additional LNG export approvals — would strip the multi-year growth optionality embedded in the current multiple.

All scans

Based on public SEC 13F filings. Funds file them up to 45 days after each quarter ends, so they show positions at quarter-end, not today. Average entry prices are estimates (filing value ÷ shares) — 13F filings don't report cost basis. The summaries, theses and risks are written by AI as a research aid — they are not financial advice or a recommendation to buy or sell any security, and they can be wrong.

SPX Lens Institutional Flow tracks the quarterly 13F filings of a watchlist of hedge funds and asset managers and flags the stocks several of them are accelerating into — new positions or sharply larger ones — while search interest, news coverage and options positioning say the retail crowd hasn't noticed yet. It is free, and a new scan is posted every Saturday by 9:00 AM ET. How to read Institutional Flow →

See where SPX is heading next. The SPX Lens chart shows key levels, live signals and an AI forecast for the next bars — free to try.

Open the live chartCreate a free account

© SPX Lens · About · Terms · Privacy — for educational purposes only, not financial advice.